Cancer Biologics Market Set to Surpass USD 185.0 Bn by 2031 Driven by Increasing Cancer Prevalence…
Wilmington, Delaware, United States, June 13, 2023 (GLOBE NEWSWIRE) -- The global cancer biologics market was valued at US$ 94.5 Bn in 2022. It is projected to expand at a CAGR of 7.7% from 2023 to 2031. Significant demand for monoclonal…